Gastric (Cardia, Body) Cancer Clinical Trials

6 recruitingLast updated: June 17, 2026

There are 6 actively recruiting gastric (cardia, body) cancer clinical trials across 6 countries. Studies span Phase 3, Phase 2, Not Applicable. Top locations include Amsterdam, Netherlands, Kyiv, Ukraine, Nanjing, Jiangsu, China. Updated daily from ClinicalTrials.gov.


Gastric (Cardia, Body) Cancer Trials at a Glance

6 actively recruiting trials for gastric (cardia, body) cancer are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 3 with 3 trials, with the heaviest enrollment activity in Amsterdam, Kyiv, and Nanjing. Lead sponsors running gastric (cardia, body) cancer studies include Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), and Assistance Publique - Hôpitaux de Paris.

Browse gastric (cardia, body) cancer trials by phase

Treatments under study

About Gastric (Cardia, Body) Cancer Clinical Trials

Looking for clinical trials for Gastric (Cardia, Body) Cancer? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastric (Cardia, Body) Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastric (Cardia, Body) Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 3

Quality of Life After Billroth II or Roux-en-Y for Gastric Cancer

Gastric (Cardia, Body) Cancer
Assistance Publique - Hôpitaux de Paris250 enrolled1 locationNCT06768164
Recruiting
Phase 2Phase 3

Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma

Esophageal CancerEsophageal CarcinomaGastric (Stomach) Cancer+3 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)290 enrolled2 locationsNCT07000253
Recruiting
Not Applicable

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

Gynecologic CancersColorectal, CancerBiliary Tract Cancer+8 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)48 enrolled1 locationNCT06731998
Recruiting

Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients

Esophageal CancerColorectal Cancer (CRC)Solid Cancer+1 more
Erasmus Medical Center66 enrolled1 locationNCT07114627
Recruiting
Phase 2Phase 3

Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer

Gastric CancerChemotherapyGastroesophageal Junction Adenocarcinoma+13 more
Ukrainian Society of Clinical Oncology150 enrolled2 locationsNCT06028737
Recruiting

The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer

Gastric CarcinomaGastric (Cardia, Body) CancerGastric Neoplasm+1 more
Lin Liu112 enrolled1 locationNCT06702683